GAS5 and lung cancer: Conversely, loss of GAS5-AS1 has been found to contribute to metastasis in lung cancer, and pan-histone deacetylase (HDAC) inhibitors inhibit NSCLC cell metastasis by increasing GAS5-AS1 expression [15].